Abys New Generation Research Inc — research payments reported

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$17,213	1
2022	Research	$247,626	106
2021	Research	$16,970	1
2020	Research	$7,520	1
2019	Research	$6,730	1

Breakdown

Who paid Research payments · program years 2019–2023

Dr.Reddy's Laboratories,Inc. $260,575 106 payments
Novartis Pharmaceuticals Corporation $35,485 4 payments

Studies the money was for Research payments · program years 2019–2023

A Phase II, Multicenter, Double-blind, Double-dummy, Placebo controlled, Randomized Study to Evaluate the Efficacy and Safety of AUR101 in patients with Moderate-to-Severe Psoriasis (INDUS-3) $243,362 105 payments
A Randomized Subject and Investigator Blinded Placebo Controlled Multi Center Study in Parallel Groups to Assess the Efficacy and Safety of Lys006 in Patients With Moderate to Severe Inflammatory Acne $35,485 4 payments
A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3) $17,213 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.